Meta Announces Prescription AI Glasses
Meta Platforms unveiled two models of Ray-Ban prescription smart glasses in the US.

Meta Platforms unveiled two models of Ray-Ban prescription smart glasses in the US. This is a new push by the tech giant to deepen its presence in the fast-growing wearable AI segment.
The new Ray-Ban Meta Blayzer Optics and Scriber Optics models target users who require everyday corrective eyewear. Meta stated that new products support nearly all prescriptions and are designed for all-day wear, with ergonomic design features like adjustable temple tips, interchangeable nose pads, and a slimmer frame. Priced from $499, the smart glasses are now available to order with retail sales beginning on 14 April in optical stores and selected international markets.
“Billions of people around the world wear glasses or contact lenses for vision correction, and many Ray-Ban Meta and Oakley Meta owners already add prescription lenses to their AI glasses,” the company explained, stating it aims to build the deepest lineup of AI glasses across every use case. Alongside the hardware launch, the tech giant announced a range of colour and lens options across its existing Ray-Ban Meta and Oakley Meta offerings, aimed at outdoor and sports applications.
It also outlined a roadmap of AI software upgrades to the wearables, including hands-free nutrition tracking, messaging summaries, access to Instagram Reels and Spotify shortcuts, and broader live translation support across 20 languages. The company is also widening international retail availability for its existing smart glasses in the coming months, adding markets including Japan, Korea, Singapore, Chile, Colombia, and Peru.
Underlining its focus on the segment, Meta highlighted it has sold millions of units across its smart glasses portfolio with partner EssilorLuxottica, with sales more than tripling year over year. Earlier this year, Meta postponed the international rollout of its latest Ray-Ban smart glasses, blaming supply shortages and strong demand in the US.